Cytotoxic Cell Dysfunction in HGA
HGA 中的细胞毒性细胞功能障碍
基本信息
- 批准号:8177048
- 负责人:
- 金额:$ 20.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:Admission activityAdrenal Cortex HormonesAnaplasma phagocytophilumAnimalsAntigen-Presenting CellsAntigensBacteremiaBacteriaBovine AnaplasmosisCD8-Positive T-LymphocytesCD8B1 geneCell physiologyCellsClinicalCytolysisDataDefectDendritic CellsDiseaseDisease modelDissociationEquus caballusEventFunctional disorderGranzymeHemophagocytic SyndromeHistopathologyHumanImmuneImmune systemIn VitroInfectionInflammationInflammation MediatorsInflammatoryInflammatory ResponseInjuryInterleukin-10Interleukin-12LaboratoriesLeadLesionLifeLightLinkMacrophage ActivationMetalloproteasesModelingMusNatural ImmunityNatural Killer CellsOrganismPathogenesisProcessProductionReactive Nitrogen SpeciesResearchSCID MiceSeptic ShockSerumSeveritiesSignal PathwaySystemic diseaseT-LymphocyteTherapeutic InterventionTick-Borne InfectionsTicksTissuesToxic Shock Syndromeadaptive immunitybasecell killingcombatcytokinecytotoxiccytotoxicityin vivokillingsmacrophagemouse modelpathogenperforinreactive oxygen intermediateresponsevector
项目摘要
DESCRIPTION (provided by applicant): This proposal is directed at dissecting the immunopathogenetic mechanisms of A. phagocytophilum infection in its dichotomous ability to cause mild and severe disease. We previously identified supportive data and provide preliminary studies that show the importance of NK and NKT cells in the induction of inflammatory disease. Moreover, studies in mice and humans both provide evidence of macrophage activation and hemophagocytic syndrome-like processes as the potential basis of inflammatory tissue injury and severe disease. Since macrophage activation and hemophagocytic syndromes are biologically linked to defective cytotoxic cell responses that lack the ability to dampen and resolve inflammation, we propose here to study whether A. phagocytophilum infection induces defects in direct cell killing by cytotoxic cells such as NK, NKT, and CD8 T lymphocytes, yet does not alter the profile of induced proinflammatory and macrophage activating cytokines. We expect to study this by in vitro analyses using purified cells and bacteria as a highly defined and controlled experimental approach and to verify the results in vivo using the mouse model we developed. We anticipate that these studies could shed light on the specific immunological abnormalities that occur with A. phagocytophilum infection and allow a more focused and intensive search for targets that could provide new opportunities for therapeutic interventions that diminish the severe consequences of infection.
PUBLIC HEALTH RELEVANCE: Human granulocytic anaplasmosis is an emerging tick-borne infection that can be mild or fatal. Research indicates that the bacterium can induce a disease that results from activation of the immune system that then is not properly turned off. This application proposes to examine in detail whether the defect can be identified in the laboratory and in a live infection model of the disease in mice. This could lead to new information on how disease occurs with this organism and others, and perhaps new information about ways to combat this infection or to change host cell function in other diseases.
描述(由申请人提供):本提案旨在剖析嗜吞噬细胞放线菌感染的免疫致病机制,了解其引起轻度和重度疾病的二分能力。我们之前确定了支持性数据并提供了初步研究,表明 NK 和 NKT 细胞在诱导炎症性疾病中的重要性。此外,对小鼠和人类的研究都提供了巨噬细胞激活和噬血细胞综合征样过程作为炎症组织损伤和严重疾病的潜在基础的证据。由于巨噬细胞激活和噬血细胞综合征在生物学上与缺乏抑制和解决炎症能力的细胞毒性细胞反应缺陷有关,因此我们在此建议研究嗜吞噬细胞放线菌感染是否会诱导细胞毒性细胞(例如 NK、NKT 和 NK)直接杀伤细胞的缺陷。 CD8 T 淋巴细胞,但不会改变诱导的促炎细胞因子和巨噬细胞激活细胞因子的特征。我们希望通过使用纯化的细胞和细菌作为高度定义和受控的实验方法进行体外分析来研究这一点,并使用我们开发的小鼠模型来验证体内结果。我们预计这些研究可以揭示嗜吞噬细胞球菌感染时发生的特定免疫异常,并可以更加集中和深入地寻找目标,从而为减少感染严重后果的治疗干预提供新的机会。
公共卫生相关性:人类粒细胞无形体病是一种新出现的蜱传感染,可能是轻微的,也可能是致命的。研究表明,这种细菌可以诱发一种疾病,这种疾病是由于免疫系统激活后未正确关闭而引起的。该申请旨在详细检查是否可以在实验室和小鼠疾病的活体感染模型中识别出该缺陷。这可能会带来关于这种生物体和其他生物体如何发生疾病的新信息,或许还可能带来关于对抗这种感染或改变其他疾病中宿主细胞功能的方法的新信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN STEPHEN Dumler其他文献
JOHN STEPHEN Dumler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN STEPHEN Dumler', 18)}}的其他基金
Host Ca2+, actin, and ATP production in rickettsia-endothelial cell dysfunction
立克次体内皮细胞功能障碍中宿主 Ca2、肌动蛋白和 ATP 的产生
- 批准号:
10509838 - 财政年份:2022
- 资助金额:
$ 20.25万 - 项目类别:
Host Ca2+, actin, and ATP production in rickettsia-endothelial cell dysfunction
立克次体内皮细胞功能障碍中宿主 Ca2、肌动蛋白和 ATP 的产生
- 批准号:
10659249 - 财政年份:2022
- 资助金额:
$ 20.25万 - 项目类别:
EHRLICHIA-GRANULOCYTE INTERACTIONS AND INFECTION
埃里克体-粒细胞相互作用和感染
- 批准号:
6637839 - 财政年份:2000
- 资助金额:
$ 20.25万 - 项目类别:
Anaplasma regulation of host granulocyte function
无形体对宿主粒细胞功能的调节
- 批准号:
7984635 - 财政年份:2000
- 资助金额:
$ 20.25万 - 项目类别:
Anaplasma regulation of host granulocyte function
无形体对宿主粒细胞功能的调节
- 批准号:
8769555 - 财政年份:2000
- 资助金额:
$ 20.25万 - 项目类别:
Anaplasma regulation of host granulocyte function
无形体对宿主粒细胞功能的调节
- 批准号:
8655827 - 财政年份:2000
- 资助金额:
$ 20.25万 - 项目类别:
相似国自然基金
下丘脑室旁核促肾上腺皮质激素释放激素神经元调控奖赏偏好行为的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
INSM1在静默性促肾上腺皮质激素细胞腺瘤发生发展中的调控机制及潜在靶向治疗研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
促肾上腺皮质激素释放因子通过CRFR1-cAMP-SphK1通路介导肥大细胞脱颗粒参与胰腺癌痛外周敏化
- 批准号:82171232
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
孕期促肾上腺皮质激素释放激素(CRH)通过引起DNA甲基化发生程序化稳定改变长期影响婴幼儿神经行为发育
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:
催产素参与双相障碍发病机制的研究:聚焦于促肾上腺皮质激素释放激素与催产素之间的平衡紊乱
- 批准号:81971268
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
- 批准号:
10820331 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别:
Corticosteroids for Acute Exacerbations of Idiopathic Pulmonary Fibrosis: Patterns and Outcomes
皮质类固醇治疗特发性肺纤维化急性加重:模式和结果
- 批准号:
10679224 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别:
Toward therapeutic targeting of liquid-liquid phase separation dynamics in skin
皮肤液-液相分离动力学的治疗靶向
- 批准号:
10679610 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别:
Deciphering the roles of eosinophils and T lymphocytes in EGID
解读嗜酸性粒细胞和 T 淋巴细胞在 EGID 中的作用
- 批准号:
10663530 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别:
DECON: A sustained topical delivery platform to treat ocular inflammation
DECON:治疗眼部炎症的持续局部给药平台
- 批准号:
10735478 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别: